Sina Publisher has published a detailed map on Chinese antibody producers. The authors come to the conclusion that a) the number of producers is consolidating, b) autoimmune diseases and cancer application accounts for 78% market share of antibody drugs, c) for the next 10 years, domestic producers will focus on the development of generic or me-better antibodies

China Bio news release, August 28, 2017